Medical therapeutics

While this book is focused on drug delivery, the value of biodegradable polymers is not limited to this field. Biodegradable polymers will be useful in other areas of medical therapeutics, such as sutures and bone plates and other types of prostheses. The polymers will also be useful in nonmedical fields, for disposable plastics, bottles, diapers and many other entities. 

Green GB, Harris IS, Lin GA, Moylan KC (eds). The Washington Manual of Medical Therapeutics, 31st ed. Baltimore, MD, Lippincott, Williams, Wilkins. 2004. 

Biological Psychopathology Illness-related neurocognitive impairment Current and past experience with medication therapeutic and side effects... 

Fig. 6.12 Cross-links between nanomaterials science and medical therapeutics. There are several regulations to pass the cross-links.

Although pharmacology usually plays a critical role in drug development, the principles of pharmacology are less often followed in the practice of medical therapeutics, which is often performed by using predetermined or empiric prescribing patterns. Clinically there is often a broader set of rela-... 

Uses. Selenium is used extensively in the manufacture and production of glass, pigments, rubber, metal alloys, textiles, petroleum and medical therapeutic agents. It is markedly photoconductive and widely used in photoelectric devices. 

In traditional medicine there are two major therapeutic approaches to the treatment of human disease surgical and medical. Surgical procedures are labour intensive and time demanding they help a limited number of individuals, one at a time, mostly in rich or developed nations. Medical therapy, on the other hand, is based on drug molecules and thus has the capacity to positively influence the lives of more people, often over a shorter time frame. Medical therapeutics offer hope in both developed and developing parts of the world—hopefully to rich and poor alike. 

For several years I tried to convince Pharmacia to work with me to develop new derivatives of hyaluronan and test them on a broad spectrum of medical therapeutic applications. But Pharmacia was not even ready to market my high molecular weight, non-inflammatory fraction of hyaluronan for the treatment of human arthritis, despite the fact that they had many successful clinical trials and that they were selling the material worldwide for treatment of arthritis in animals. I believe that this was because they were not ready to invest in a substantially larger manufacturing facility for hyaluronan. They were, however, ready to support me financially in my research and development effort to develop new hyaluronan derivatives. 

Eldor A, Orevi M, Rigbi M. The role of the leech in medical therapeutics. Blood Reviews 19% 10 201-209... 

Much has been written regarding a proper approach to the development of racemic mixtures of drugs, and whether such drugs are even candidates for development (1,8,22,37-42). As clinical pharmacologists and medical practitioners, we shall advance a point of view that represents a compromise among the various camps, but one that we believe can effectively serve medical therapeutics now and in the future. The previous material in this paper represents a summary, not a comprehensive review, of the database from which attitudes, opinions, and therapeutic approaches can be formulated. 

Toxins in general are potent poisons. Nevertheless, the selectivity of action of some of these toxins means they have been harnessed in medical therapeutics (and even more widely in experimental pharmacology and physiology). Toxins that have been, or still are. us in medicine include atropine, botulinum toxin, cardiac glycosides, coichidne, eserine, hyoscine, picrotoxin, morphine, ouabain, strychnine, veratridine, vinca alkaloids and many more. All these work by an action at a defined molecular site, whether ion channel, neurotransmitter receptor, enzyme, pump or intracellular organelle. Those toxins that work at nonneuronal, or not specifically at neuronal sites (e.g. cholera toxin, pertussis toxin, cardiac glycosides, phospholipases) are discussed under TOXINS. 

Ahya SL, Flood K, Paranjothi S, Schaiff R, eds. The Washington manual of medical therapeutics, 30th ed. Philadelphia Lippincott, Williams and Wilkins, 2001 3-75. 

Until definitive medical therapeutics for sulfur mustard are fielded, the medical caregivers will have to rely on symptomatic treatments and sound medical judgments. Historically derived treatments, as presented in the Textbook of Military Medicine (Sidell et al., 1997) and the Medical Management of Chemical Casualties Handbook (1999) prepared by the Chemical Casualty Care Division of the U.S. Army Medical Research Institute of Chemical Defense, can also be of assistance. 

Regelson W. DHEA, melatonin and hormone replacement. In Updates, Anti-aging Medical Therapeutics, Vol 1. Health Quest Publications, 1997 75-81. 

Dr. William Cook, in his book A Compend of the Newer Materia Medica, recounted the accepted uses of Serenoa "It influences the sensory and sympathetic nerve peripheries, the mucous membranes and reproductive organs of both sexes." T. J. Lyle, M.D., in his textbook Physio-Medical Therapeutics, Materia Medica and Pharmacy, also reinforced the prevailing uses of Serenoa. He noted an interesting formula for a saw palmetto compound that he recommended as an excellent tonic diuretic the ingredients were Serenoa, parsley, cola nut, sandalwood, and essential oils. 

Lyle, J.T., M.D. Physio-Medical Therapeutics, Materia Medica and Pharmacy. Salem, OH J.M. Lyle and Brothers, 1897. 

Medical therapeutic system manufacturing, CO 1979 400-3,600 NIOSH 1980d... 

---